معرفی
Stephani Stancil, Ph.D., APRN, is an assistant professor at the University of Missouri-Kansas City School of Medicine and an adolescent medicine clinician-scientist at Children's Mercy Kansas City. Her work bridges clinical practice and translational research in adolescent precision therapeutics, focusing on psychiatric medications, neuroimaging, and pharmacodynamics in teens. She previously held a KL2 Scholar position and currently leads NIH-funded studies on eating disorders and vaping cessation programs.
- Collaborates with Hoglund Biomedical Imaging Center and University of Kansas Medical Center
- Developed the Teen Research Advisors (TRA) program for youth engagement in research
Research Focus
Dr. Stancil specializes in developing precision therapeutics for adolescent mental health conditions by understanding individual variability in drug exposure and response. Her work includes:
- Neuroimaging to detect psychopharmacologic drug action in the adolescent brain
- Using magnetic resonance spectroscopy (MRS) to measure brain drug concentrations
- Designing personalized vaping cessation programs integrating genetics
Recognition
- Receipient of NIMH K23 Award for neuroimaging research in adolescent mental health
- Broderick Crawford Community Partnership Awardee for expanding the TRA program
- KL2 Scholar alumni with Frontiers Clinical and Translational Science Institute
Dr. Stancil maintains over $870,000 in research funding and continues to grow her multidisciplinary team at the intersection of clinical pharmacology and adolescent medicine.
